# Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

> **NCT02021942** · PHASE2 · COMPLETED · sponsor: **Prof. Dr. Berthold Schalke** · enrollment: 16 (actual)

## Conditions studied

- Primary Inoperable Thymoma
- Local Recurrent Thymoma

## Interventions

- **DRUG:** SOM230 LAR

## Key facts

- **NCT ID:** NCT02021942
- **Lead sponsor:** Prof. Dr. Berthold Schalke
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021942, "Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02021942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*